At the time of writing, Q32 Bio Inc [QTTB] stock is trading at $3.95, up 10.64%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The QTTB shares have gain 82.03% over the last week, with a monthly amount glided 104.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Q32 Bio Inc [NASDAQ: QTTB] stock has seen the most recent analyst activity on February 11, 2025, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $4 from $20. Previously, BMO Capital Markets downgraded its rating to Market Perform on February 11, 2025, and dropped its price target to $3. On December 11, 2024, downgrade downgraded it’s rating to Equal Weight and revised its price target to $16 on the stock. Raymond James downgraded its rating to a Outperform and decreased its price target to $22 on December 11, 2024. Leerink Partners downgraded its rating to a Market Perform and reduced its price target to $9 on December 11, 2024. Guggenheim downgraded its rating to Neutral for this stock on December 11, 2024. In a note dated December 06, 2024, BMO Capital Markets initiated an Outperform rating and provided a target price of $64 on this stock.
For the past year, the stock price of Q32 Bio Inc fluctuated between $1.35 and $53.17. Currently, Wall Street analysts expect the stock to reach $63.83 within the next 12 months. Q32 Bio Inc [NASDAQ: QTTB] shares were valued at $3.95 at the most recent close of the market. An investor can expect a potential return of 1515.95% based on the average QTTB price forecast.
Analyzing the QTTB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.79, Equity is -27.1 and Total Capital is -1.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Q32 Bio Inc [NASDAQ:QTTB] has a current ratio of 5.06. Also, the Quick Ratio is 5.06, while the Cash Ratio stands at 4.75.
Transactions by insiders
Recent insider trading involved Morrison Jodie Pope, CEO, that happened on Aug 26 ’25 when 10494.0 shares were sold. Chief Scientific Officer, Violette Shelia M. completed a deal on Aug 26 ’25 to sell 2990.0 shares. Meanwhile, CFO and President Kalowski Lee sold 4240.0 shares on Aug 26 ’25.
